(Q45878780)

English

The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

author name string

H Pergantou

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

P Xafaki

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

E Adamtziki

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

P Koletsi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

A Komitopoulou

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

H Platokouki

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

publication date

1 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

18

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

e66-7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

Treatment for patients with type 3 von Willebrand disease and alloantibodies: a case report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02799.X

21 January 2018

Anaphylaxis in patients with congenital bleeding disorders and inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02799.X

21 January 2018

Use of recombinant factor VIIa in inherited and acquired von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02799.X

21 January 2018

The use of recombinant activated factor VII in congenital and acquired von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2012.02799.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2012.02799.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22531022

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45878780&oldid=2088292815"